July 19, 2022 — Employing artificial intelligence to help improve outcomes for people with cardiovascular disease is the focus of a three-year, $15 million collaboration among Cornell Tech, the Cornell Ann S.

July 18, 2022 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the CE Mark submission for its MAGiC catheter.

July 18, 2022 —  scPharmaceuticals Inc., a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced positive results from the AT HOME-HF Pilot study, a Phase 2, multicenter, randomized study that compared scPharmaceuticals’ investigational prod